This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nordmark Pharma Gmbh. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Annika Müller-Lucks: Innovator in Pharmaceutical Solutions
Introduction
Annika Müller-Lucks is a notable inventor based in Uetersen, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solutions for treating exocrine pancreatic insufficiency. Her work is especially relevant for patients with cystic fibrosis and in pediatric care.
Latest Patents
Annika Müller-Lucks holds a patent for an aqueous solution of burlulipase comprising calcium ions. This invention relates to a solution that contains burlulipase, which is characterized by the inclusion of calcium ions. The pharmaceuticals derived from this invention are designed to treat exocrine pancreatic insufficiency, making them particularly beneficial for patients suffering from cystic fibrosis.
Career Highlights
Throughout her career, Annika has worked with reputable companies such as Nordmark Pharma GmbH and Nordmark Arzneimittel GmbH & Co. KG. Her experience in these organizations has allowed her to develop innovative pharmaceutical solutions that address critical health issues.
Collaborations
Annika has collaborated with professionals like Richard Fuhrherr and Katharina Rützel, contributing to her success in the pharmaceutical industry.
Conclusion
Annika Müller-Lucks is a pioneering inventor whose work in pharmaceutical solutions has the potential to improve the lives of many patients. Her innovative approach to treating exocrine pancreatic insufficiency showcases her commitment to advancing healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile